| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6823642 | Schizophrenia Research | 2015 | 7 Pages |
Abstract
The observed time to relapse superiority of paliperidone palmitate over oral antipsychotics provides further evidence for the value of long-acting injectable antipsychotic therapies in the treatment of schizophrenia, including during the early stages of illness.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Andreas Schreiner, Kaire Aadamsoo, A. Carlo Altamura, Manuel Franco, Philip Gorwood, Nikolaj G. Neznanov, Juan Schronen, Alp Ucok, Mathias Zink, Adam Janik, Pierre Cherubin, Marjolein Lahaye, Ludger Hargarter,